Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Reports Millions In Unpaid GDUFA Program Fees

Oct 07 2019

• By Derrick Gingery

Franklin Currency_1099429328_1200.jpg — The GDUFA carryover balance still increased in FY 2018 because collections again outpaced obligations. • Source: Shutterstock

Related Content

The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

Apr 08 2018

ANDA Submissions To US FDA Expected To Decline; Generic User Fees For FY 2019 Will Rise

Jul 29 2018

Generic Companies Race To Withdraw ANDAs

Jul 08 2019

Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree

Jun 24 2013

Biosimilar User Fee Collections Drop Well Below Estimates, But US FDA Not Worried

Jun 10 2019

User Fee Delinquencies Rising At US FDA After PDUFA Redesign

Oct 02 2019

FDA's GDUFA War Chest Grows, And Industry May Look For Lower Fees

Jun 08 2015

Generic User Fee Hikes Could Disrupt US FDA Drug Pricing Campaign

Aug 28 2017

Inside The ANDA Parking Lot

Jun 14 2018

Is Bloom Gone From Rosy ANDA Approvals Figures?

Nov 12 2018

Generic Industry Consolidating But Still Mysterious

Jun 07 2017

Additional Topics

United States Generic Drugs Review Pathway FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window